Locally advanced breast implant-associated anaplastic large-cell lymphoma: a combined medical-surgical approach
G.G. Caputo, A. Alban, L. D’Alì, L. Mariuzzi, F. Galvano, P.C. Parodi Plastic and Reconstructive Surgery, Azienda Sanitaria Universitaria Integrata di Udine, Udine, Italy. sblenda@yahoo.it
OBJECTIVE: Breast implant-associated anaplastic large-cell lymphoma (BIA-ALCL) is a rare form of non-Hodgkin’s T-cell lymphoma that develops around breast implants.
CASE PRESENTATION: This report illustrates the case of a patient affected by a locally advanced BIA-ALCL which infiltrated the thoracic wall (stage T4N0M0) following implant-based reconstruction after left mastectomy. Given the initial inoperability due to the patient’s poor general condition, the treatment plan provided for a primary cycle of systemic neoadjuvant immunotherapy/chemotherapy, surgical removal of the mass, and subsequent systemic chemotherapy/immunotherapy. This resulted in complete remission – the patient remained disease-free even over a year later – without the need for adjuvant radiotherapy.
CONCLUSIONS: Our real-life case shows how the existing guidelines can be successfully adapted as part of an individualized approach to advanced and/or difficult cases.
Free PDF DownloadThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
To cite this article
G.G. Caputo, A. Alban, L. D’Alì, L. Mariuzzi, F. Galvano, P.C. Parodi
Locally advanced breast implant-associated anaplastic large-cell lymphoma: a combined medical-surgical approach
Eur Rev Med Pharmacol Sci
Year: 2021
Vol. 25 - N. 9
Pages: 3483-3488
DOI: 10.26355/eurrev_202105_25830